Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 219 - Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
Patents for C07C 219 - Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton (3,521)
01/2004
01/08/2004WO2004003102A2 Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use
01/08/2004US20040006243 Reacting a phenylketone with a silylcyanide in the presence of an asymmetric catalyst to form a siloxynitrile, and reacting the siloxynitrile with a reducing agent to obtain an aldehyde and oxidizing the aldehyde, or hydrolysis of siloxynitrile
01/08/2004US20040006059 C-nitroso compounds and use thereof
01/07/2004CN1133465C Absorption enhancers for topical pharmaceutical formulations
01/06/2004US6673884 Quaternization of n,n-dimethylamino ethyl acrylate via reaction with 1,3-bis-dimethylamino-2 propanol, triethylamine, and phenothiazine (as stabilizer); for use as cationic polymeric flocculants in water treatment
12/2003
12/31/2003WO2003072055A3 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors
12/30/2003US6670508 Process for manufacturing the chloride of 1,3-bis- (dimethylbenzylammonium) isopropyl, acrylate alone or mixed with other monomers, and corresponding (co) polymers
12/25/2003US20030236266 Anticancer agents; viricides; infection therapy
12/18/2003WO2003104178A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)
12/18/2003WO2003103650A1 Active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol
12/18/2003US20030232891 For therapy of pain
12/18/2003CA2487866A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)
12/16/2003US6664394 As inactivator of antigen- specific T cells is useful in the prophylaxis or therapy of autoimmune diseases, disorders involving an autoimmune component or neoplastic diseases
12/10/2003EP1368299A2 Substituted c-cyclohexylmethylamine derivatives
12/10/2003EP0980352B1 Softening active substance for textiles and textile-softening compositions containing it
12/10/2003EP0971885B1 Process for preparing indane-like compounds
12/04/2003WO2003099769A1 Anilino liver x-receptor modulators
12/04/2003CA2486644A1 Anilino liver x-receptor modulators
12/02/2003US6656498 Cationic liposomes for gene transfer
11/2003
11/30/2003CA2429058A1 Method of producing oxybutynin and its derivatives
11/27/2003WO2002100813A3 Modulators of peroxisome proliferator activated receptors
11/20/2003WO2003008559A3 Novel analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders
11/20/2003US20030216477 Adrenergic blocking agent
11/19/2003EP1362844A1 Benzylamine analogue
11/18/2003US6649780 Cationic lipids
11/13/2003WO2003093218A1 Method for continuously producing dimethylaminoethyl acrylate
11/11/2003US6646156 (Meth)acryloyl-group-containing carbamoyl halides and production process therefor
11/11/2003CA2363543C Fatty amine derivatives of butylated hydroxy toluene for the protection of surfaces from physical and chemical degradation
11/06/2003WO2003091204A1 Phenethanolamine derivatives
11/05/2003EP1358197A1 Hybrid protecting groups
11/05/2003CN1126732C Process for preparing benzoxy-2-[(1-methyl-2-[3-(trifluoromethyl)- phenyl)ethyl]amino]carbethoxy hydrochloride
10/2003
10/30/2003WO2003088915A2 Novel sodium channel blockers
10/30/2003CA2482035A1 Novel sodium channel blockers
10/22/2003EP1354869A1 Process for producing quaternary ammonium salt having ester group
10/22/2003CN1125036C Process for manufacture of aqueous solutions of unsaturated quaternary ammonium salts
10/16/2003WO2003032969B1 Anti-glycation agents for preventing age-, diabetes-, and smoking-related complications
10/15/2003EP1198449B1 Process for preparing esterquats
10/15/2003CN1449375A Use of pamoic acid or one of derivatives or analogs thereof for preparing a medicament used for treating diseases
10/14/2003US6632955 Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for preparing the same
10/09/2003WO2003082800A1 Compounds that stimulate glucose utilization and methods of use
10/09/2003WO2003082205A2 Compounds and methods
10/09/2003US20030191316 A 2-fluorocycloalkyl-2-hydroxy-2-phenyl-ethanoyl)oxy amine salt derivatives; antagonist for treating diseases associated with muscarine M3 receptors, respiratory system disorders; side effect reduction, use as inhalants
10/09/2003US20030191264 Reacting a hydroxyalkylamine compound with methyl(meth)acrylate in presence of transesterification catalyst with removal of methanol by-product, free-radical polymerizing the product, alkylating the polymer
10/07/2003US6630492 Lymphocyte function antigen-1 antagonists
10/02/2003WO2002030870A3 Substituted c-cyclohexylmethylamine derivatives
10/01/2003EP1104400B1 Method for making aqueous solutions of unsaturated quaternary ammonium salts
10/01/2003CN1446193A Aminoadamantane derivatives as therapeutic agents
10/01/2003CN1446192A Method for making aqueous solutions of (Meth) acryloyoxyethylbenzy-uimethylammonium chlorides
09/2003
09/30/2003US6627662 3-amino-propoxyphenyl derivatives (I)
09/24/2003CN1122018C 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
09/23/2003US6624211 Dental materials with extendable work time, kits, and methods
09/18/2003WO2003076397A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003US20030176286 Mixture with adjuvants; bioavailability
09/18/2003CA2479065A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/17/2003CN1121401C Aminophenol derivates
09/16/2003US6620845 For therapy and prophylaxis of neurological diseases
09/12/2003WO2003032969A3 Anti-glycation agents for preventing age-, diabetes-, and smoking-related complications
09/12/2003CA2477728A1 Open-chain alkoxyamines and their corresponding nitroxides for controlled low temperature radical polymerization
09/11/2003WO2003074572A1 Open-chain alkoxyamines and their corresponding nitroxides for controlled low temperature radical polymerization
09/10/2003EP1127871B1 New esters derived from substituted phenyl-cyclohexyl compounds
09/09/2003CA2222062C Process for the preparation of tertiary aminocarbonates and aminoethers
09/04/2003WO2003072055A2 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors
09/04/2003US20030166721 Choline derivative for the treatment of alzheimer's disease
09/04/2003CA2477218A1 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors
09/03/2003EP1340754A1 Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
09/03/2003CN1440395A COLCHINOL derivatives as vascular damaging agents
08/2003
08/28/2003US20030161808 Ester quaternary mixtures
08/21/2003US20030158176 Quaternary ammonium compounds
08/20/2003EP1144357B1 Method for making aqueous solutions of unsaturated quaternary ammonium salts
08/20/2003EP1144356B1 Method for making aqueous solutions of unsaturated quaternary ammonium salts
08/20/2003CN1437574A Method for preparing amino alkyl (meth) acrylates
08/19/2003US6608228 Fluorenyl and dibenzosuberenyl moieties; efficient
08/14/2003US20030153544 Fatty acid derivatives
08/13/2003CN1436042A Use of amine compounds with improved biodegradability as adjuvants for pesticides and fertilisers
08/13/2003CN1435435A Polymer with biocidal effect, preparing process thereof and use of same
08/06/2003EP1332139A2 Anticancer agents based on regulation of protein prenylation
08/06/2003CN1434793A Method for the production of esters of unsaturated carboxylic acids
07/2003
07/31/2003US20030144275 Decyclization of oxabenzonorbornadienes or azabicyclic compounds in the presence of catalysts to form naphthalenes, such as 2-methoxy-1,2-dihydronaphthalen-1-ol, used as analgesics, anticarcinogens or viricides; catalysis
07/30/2003EP1331231A2 Polymers having biocidal activity, process for their preparation and their use
07/30/2003EP0783482B1 Cationic transport reagents
07/30/2003CN1433396A Pharmaceutical compounds
07/29/2003US6600059 Protecting cells from injury due to intrinsic membrane lysis, oxidation and/or invasion by destructive agents. Even more particularly, the present invention provides compositions and methods for treating or prophylactically inhibiting
07/29/2003CA2417537A1 Polymers with biocidal action, process for their preparation and their use
07/24/2003US20030139599 Method for the production of esters of unsaturated carboxylic acids
07/23/2003EP1328506A2 Novel intermediates for use in retinoid synthesis
07/23/2003EP0898559B1 Cytoprotective compounds
07/10/2003US20030130236 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
07/09/2003EP1324979A2 Ionic liquids and their use as solvents
07/03/2003US20030125489 Open chain alkoxyamine compounds and their use as polymerization regulators
07/03/2003US20030125329 Treating atherosclerosis and other coronary artery diseases
07/03/2003US20030125328 Treating atherosclerosis and other coronary artery diseases
07/01/2003US6586634 Reacting in solvent at elevated temperature mixture of enantiomers of cis-1-amino-2-indanol with (R,R)-tartaric acid and methanol, crystallizing optically enriched (1S,2R)-1-amino-2-indanol-(R,R)-tartrate methanol solvate
07/01/2003US6586559 Polyamide oligomers
07/01/2003US6586433 Anticholesterol agents; antilipemic agents; cardiovascular disorders
06/2003
06/26/2003US20030119833 Treating cardiovascular diseases
06/24/2003US6583183 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
06/24/2003CA2126337C 2-amino-1,3-propanediol compound and immunosuppressant
06/19/2003US20030114454 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/12/2003WO2003047499A2 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting
06/12/2003US20030109528 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ... 36